ASX Cannabis Stocks in 2026: Is the risk worth the reward?

It has been a while since we've looked at ASX Cannabis Stocks, and we are sure we are not the only ones to have paid little attention to it. Nonetheless,…

ByNick Sundich

13

Sep 2024

Healthcare Stocks Mid Cap Stocks News Penny Stocks Small Caps Stocks

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and New Zealand continues to mature in 2024. In spite…

ByNick Sundich

06

Sep 2024

Agriculture Stocks Cannabis Stocks Healthcare Stocks Mid Cap Stocks Small Caps Stocks

Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017

Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian Government's Office of Drug Control in March 2017. During this time,…

ByNick Sundich

ASX Cannabis Stocks in 2026: Is the risk worth the reward?

The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!

Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017

2020, the Golden Year

Investing in the Year of the Rat

Market trouble spots to avoid in 2020

Add Your Heading Text Here